TG Therapeutics Inc Capital Reinvestment Ratio

Latest as of June 2026: 0.02x

TG Therapeutics Inc capital reinvestment ratio. TG Therapeutics Inc (TGTX) has a Capital Reinvestment Ratio of 0.02x as of June 2026, meaning it reinvests 0% of its operating cash flow ($21.37 Million) in capital expenditures ($344.00K). Check TGTX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$21.37 Million

USD

Capital Expenditures

$344.00K

USD

Data as of

Jun 2026

Most recent filing

TG Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

TG Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see cash flow conversion of TG Therapeutics Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow